-+ 0.00%
-+ 0.00%
-+ 0.00%

REGENERON PHARMACEUTICALS, INC. : LEERINK PARTNERS RAISES TARGET PRICE TO $824 FROM $641

Reuters·08/17/2026 10:20:59

Please log in to view news